Founded in 1991, Myriad Genetics emerged in the discovery and sequencing of disease-related genes and the elucidation of their biochemical pathways. Myriad has two wholly owned subsidiaries - Myriad Pharmaceuticals, which develops and intends to market therapeutic compounds, and Myriad Genetic Laboratories, which develops and markets proprietary predictive medicine products.
R&D
To view this information, you must subscribe to PL Intelligence.
Partnerships
To view this information, you must subscribe to PL Intelligence.
Deals
To view this information, you must subscribe to PL Intelligence.
Senior management
To view this information, you must subscribe to PL Intelligence.
Board of directors
To view this information, you must subscribe to PL Intelligence.
Head office
Myriad Genetics
320 Wakara Way
Salt Lake City
Utah
84108 Utah
All rights reserved. Terms and Conditions | Contact us
